Ranks second overall and first for long-term investment and social
responsibility in industry category
MADISON, N.J., March 3 /PRNewswire-FirstCall/ -- Quest Diagnostics
Incorporated (NYSE: DGX), the world's leading provider of diagnostic testing,
information and services, has again been named to FORTUNE magazine's list of
the World's Most Admired Companies. Quest Diagnostics ranked second in the
"Health Care" category of "Pharmacy and Other Services." The 2009 ranking is
the second consecutive year that the company has been included on FORTUNE's
Most Admired Companies list. The company advanced to second place from third
in 2008. The new World's Most Admired Companies list is widely considered the
definitive report card on corporate reputations.
"This prestigious recognition reflects the dedicated efforts of our 43,000
employees to put patients first and provide superior diagnostic services,"
said Surya N. Mohapatra, Ph.D., Chairman and CEO of Quest Diagnostics. "We
are particularly gratified to have ranked number one in our industry category
for long-term investment, which demonstrates support for our strategy and
vision."
FORTUNE's list of the World's Most Admired Companies is based on surveys
of more than 4,000 executives, directors and securities analysts of companies
they admire most in their industry based on nine criteria: innovation, people
management, use of corporate assets, quality of management; social
responsibility; financial soundness, long-term investment, quality of products
and services, and global competitiveness. For 2009, FORTUNE published one
list rather than separate World's Most Admired and America's Most Admired
lists in order to better represent the competitive landscape faced by today's
companies.
The full list and related stories appear in the March 16 issue of FORTUNE,
available on newsstands on Monday, March 9th, and now at:
http://money.cnn.com/magazines/fortune/mostadmired/2009/index.html
About Quest Diagnostics
Quest Diagnostics is the world's leading provider of diagnostic testing,
information and services that patients and doctors need to make better
healthcare decisions. The company offers the broadest access to diagnostic
testing services through its network of laboratories and patient service
centers, and provides interpretive consultation through its extensive medical
and scientific staff. Quest Diagnostics is a pioneer in developing innovative
diagnostic tests and advanced healthcare information technology solutions that
help improve patient care. Additional company information is available at
www.questdiagnostics.com.
The statements in this press release that are not historical facts or
information may be forward-looking statements. These forward-looking
statements involve risks and uncertainties that could cause actual results and
outcomes to be materially different. Certain of these risks and uncertainties
may include, but are not limited to, competitive environment, changes in
government regulations, changing relationships with customers, payers,
suppliers and strategic partners and other factors described in the Quest
Diagnostics Incorporated 2007 Form 10-K and subsequent SEC filings.
SOURCE Quest Diagnostics Incorporated
CONTACT: Wendy Bost (Media), +1-973-520-2800;
or Laure Park (Investors),
+1-973-520-2900,
both of Quest Diagnostics
Web Site: http://www.questdiagnostics.com
(DGX)